EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base editor ...

A 19-year-old Canadian man becomes the first human cured through prime gene editing after doctors corrected a rare genetic ...

One of the more famous companies in this niche is CRISPR Therapeutics (NASDAQ: CRSP). Is this mid-cap company worth ...

A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...

Researchers in Mexico are turning their focus towards a revolutionary technique to enhance crop resilience. According to News Arena India, the International Maize and Wheat Improvement Center, also ...

Tools like CRISPR-Cas9 are creating new opportunities for innovation in St. Louis, as well as risks around IP protection and regulation.

Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr Therapeutics Ag (NASDAQ:CRSP) shares are up 16% over the past 12 months.

Apellis Pharmaceuticals (NASDAQ:APLS) executives outlined a three-part strategy for the company at TD Cowen’s 46th Annual ...

Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol.It's very early-stage research, tried in only a few ...